WINNERS & LOSERS: Threat to Vistry; Plus500 plans more share buybacks
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday. Read More
| Price | 1,896.00p on 11-08-2026 at 18:35:06 |
|---|---|
| Change | -31.50p -1.63% |
| Buy | 1,896.50p |
| Sell | 1,895.50p |
| Last Trade: | Sell 3,438.00 at 1,896.00p |
| Day's Volume: | 4,542,799 |
| Last Close: | 1,896.00p |
| Open: | 1,926.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,894.00p - 1,948.50p |
| 52wk Range: | 1,401.50p - 2,282.00p |
| Market Capitalisation: | £75.95b |
| VWAP: | 1,910.52601p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 3,438 | 1,896.00p | SI Trade Suspected SELL Trade |
16:53:47 - 11-Aug-26 |
| Sell* | 23 | 1,896.00p | Automatic Execution |
16:38:38 - 11-Aug-26 |
| Sell* | 47 | 1,896.00p | Automatic Execution |
16:36:14 - 11-Aug-26 |
| Buy* | 2,216 | 1,896.00p | Automatic Execution |
16:35:21 - 11-Aug-26 |
| Unknown* | 871 | 1,896.00p | SI Trade |
16:35:21 - 11-Aug-26 |
| Buy* | 4,432 | 1,896.00p | Automatic Execution |
16:35:21 - 11-Aug-26 |
| Buy* | 4,432 | 1,896.00p | Automatic Execution |
16:35:21 - 11-Aug-26 |
| Unknown* | 1,719,008 | 1,896.00p | Uncrossing Trade |
16:35:21 - 11-Aug-26 |
| Buy* | 337 | 1,896.00p | Automatic Execution |
16:29:59 - 11-Aug-26 |
| Buy* | 2 | 1,896.00p | Automatic Execution |
16:29:59 - 11-Aug-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 11th Aug 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 3rd Aug 2026 3:00 pm | RNS | Total Voting Rights |
| 30th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 28th Jul 2026 12:05 pm | RNS | New GSK flagship R&D centre in Cambridge |
| 28th Jul 2026 12:00 pm | RNS | 2nd Quarter Results |
| 28th Jul 2026 11:06 am | RNS | Hansoh positive 2nd Phase III results for Riz-Rez |
| 24th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 24th Jul 2026 3:00 pm | RNS | Admission to Trading |
| 22nd Jul 2026 5:22 pm | RNS | Jideytro approved in US for certain lung cancers |
| 20th Jul 2026 7:00 am | RNS | Bexsero 1-dose booster EMA file acceptance |